Acadia Healthcare Company (ACHC) Osake Kurssi
Acadia Healthcare Company Kurssi
Liikevaihto on kasvanut 31,3 % vuodessa viimeisten 18 vuoden aikana 3,31 Mrd. USD:een. Osakekohtainen tulos on kasvanut 20,7 % vuodessa viimeisten 15 vuoden aikana. Acadia Healthcare Companyn nettomarginaali on nyt −33,3 %, laskenut 8,2 %:sta muutama vuosi sitten. Analyytikoiden mediaanitavoitehinta on 31,00 USD, eli yli nykyhintaa 3,0 %. 20 analyytikosta 13 suosittaa ostoa — kokonaiskonsensus on Osta.
Acadia Healthcare Company osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Acadia Healthcare Company liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Acadia Healthcare Company -osakkeesta
The business model of Acadia Healthcare Company Inc is centered around providing behavioral healthcare services. As a leading provider in the industry, Acadia operates a network of psychiatric hospitals, residential treatment centers, outpatient clinics, and therapeutic schools. Its comprehensive range of services caters to individuals with behavioral health disorders and substance use disorders, aiming to offer personalized care and support to patients across their treatment journey. By focusing on quality care, patient satisfaction, and strategic acquisitions, Acadia Healthcare Company Inc has established itself as a trusted provider in the behavioral healthcare industry.
Acadia Healthcare Company Inc is primarily active in the healthcare industry.
The main competitors of Acadia Healthcare Company Inc in the market are Universal Health Services, Inc., HCA Healthcare, Inc., and Tenet Healthcare Corporation.
Acadia Healthcare Company Inc is a renowned healthcare facility provider specializing in behavioral health services. Established in 2005, Acadia has grown into a leading global network of treatment centers, psychiatric hospitals, and outpatient clinics. The company operates across the United States, the United Kingdom, and Puerto Rico, offering comprehensive services for individuals facing mental health and addiction challenges. Emphasizing personalized care and evidence-based approaches, Acadia strives to improve patients' quality of life, providing specialized programs tailored to different age groups and needs. Continuously expanding its footprint and delivering exceptional behavioral healthcare, Acadia Healthcare Company Inc remains committed to assisting individuals on their journey to recovery.
Acadia Healthcare Company Inc, a renowned leader in behavioral healthcare, has accomplished several significant milestones over the years. The company has expanded its footprint, both domestically and internationally, establishing a vast network of facilities and treatment centers across various regions. Acadia Healthcare has consistently emphasized its commitment to quality patient care, investing in cutting-edge research, modern treatment methodologies, and innovative programs. The company's strong financial performance and successful acquisitions demonstrate its ability to navigate and thrive within the challenging healthcare industry. Furthermore, Acadia Healthcare has received accolades for its corporate governance practices and dedication to regulatory compliance, solidifying its position as a trusted provider in the behavioral healthcare sector.
Acadia Healthcare Company Inc is primarily present in the United States of America.
Acadia Healthcare Company Inc. represents values and a corporate philosophy centered around exceptional patient care and delivery of high-quality behavioral health services. With a commitment to clinical excellence, Acadia ensures patient safety, dignity, and respect while offering evidence-based treatment for individuals with mental health and addiction disorders. The company follows a patient-centered approach, focusing on personalized care plans tailored to meet each patient's unique needs. Acadia Healthcare Company Inc. also values integrity, transparency, and teamwork, fostering collaboration among their dedicated professionals and maintaining strong ethical standards.
Analyytikot asettavat tällä hetkellä Acadia Healthcare Company-osakkeelle keskimääräisen tavoitehinnan 32,00 USD (mediaani: 31,00 USD), mikä merkitsee +6,4 % viimeisimpään hintaan verrattuna. Konsensus perustuu 20 analyytikkoarvioon.
Acadia Healthcare Company Analyytikkojen kursstavoitteet 2026
20 analyytikkoa arvioi tällä hetkellä Acadia Healthcare Company-osaketta: 13 suosittaa ostoa, 6 pitoa ja 1 myyntiä. Vuodelle 2026 analyytikot odottavat Acadia Healthcare Company-yhtiöltä 3,43 Mrd. USD liikevaihtoa ja 1,56 USD osakekohtaista tulosta.
Acadia Healthcare Company Analyytikkojen kursstavoitteet 2026
Nykyisellä valuuttakurssilla Acadia Healthcare Company-osake noteerataan hintaan 26,80 EUR (30,08 USD).
Acadia Healthcare Company-osake (ACHC) on listattuna 3 pörssissä, muun muassa: NASDAQ (ACHC), Frankfurt (7RA.F), München (7RA.MU).
Acadia Healthcare is an American company specializing in providing mental health services. It operates through its subsidiaries to serve patients in over 40 states in the US, the United Kingdom, and Puerto Rico. The company offers services for diagnosing and treating mental disorders, detoxification from substance abuse, and rehabilitation for addiction. It has inpatient and outpatient treatment options, focusing on creating safe and supportive environments for patients to concentrate on their recovery. Acadia Healthcare also provides administration services for mental health facilities, including recruitment, training, marketing, and compliance. It has made several acquisitions, such as the Priory Group and CRC Health Group, to expand its presence in the mental health and addiction treatment market. Overall, Acadia Healthcare aims to offer a wide range of services to support mental health and addiction treatment, utilizing both inpatient and outpatient programs, and ensuring efficient business processes for facilities offering mental health services.
odotettu liikevaihto Acadia Healthcare Company on 3,43 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Acadia Healthcare Company on 140,81 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Acadia Healthcare Company:n hinta-voitto-suhde (P/E) on tällä hetkellä 19,32. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Acadia Healthcare Company-osakkeen arvostusta.
Acadia Healthcare Company:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,79. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Acadia Healthcare Company-osakkeen arvostuskennuslukuna.
Acadia Healthcare Company:n Eulpool-laatuscore on 3/10.
Acadia Healthcare Company:n ISIN on US00404A1097. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Acadia Healthcare Company:n WKN on A1JNMF. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Acadia Healthcare Company:n ticker on ACHC. Tämä pörssinoteeraus käytetään Acadia Healthcare Company-osakkeiden kauppaan pörssissä.
Acadia Healthcare Company osake
Acadia Healthcare Company vertaisryhmä
Acadia Healthcare Company Ticker
Acadia Healthcare Company FIGI
Kaikki tunnusluvut ja syvällinen analyysi Acadia Healthcare Company:sta
Meidän osakeanalyysimme Acadia Healthcare Company-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Acadia Healthcare Company:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: